Target intelligence / Profile preview

Eukaryotic translation initiation factor 2B subunit epsilon (eIF2Bε)

Target
eIF2Bε
Molecular classification
Enzyme, Guanine nucleotide exchange factor (GEF), Translation factor
01

Overview

Eukaryotic translation initiation factor 2B subunit epsilon (eIF2Bε) is the catalytic subunit of eIF2B, a multi-subunit enzyme complex that acts as a guanine nucleotide exchange factor for eukaryotic initiation factor 2 (eIF2), a key GTPase in protein translation initiation[1][2][5]. eIF2Bε, encoded by the *EIF2B5* gene, facilitates the exchange of GDP for GTP on eIF2, regulating protein synthesis rates in response to cellular conditions[4][6]. The complex is critical for modulating the integrated stress response (ISR), as its inactivation under stress conditions represses general translation but enhances selective expression of stress-response proteins[2]. Mutations in the *EIF2B5* gene are causative for leukoencephalopathy with vanishing white matter, a progressive neurodegenerative disorder[4]. The eIF2B complex, particularly its epsilon subunit, is considered a potential therapeutic target for modulating protein synthesis in neurodegenerative diseases and other ISR-related pathologies[2][6].

Other names
EIF2B5eIF-2B epsilonEIF2BepsilonCACHCLEVWM5LVWMeukaryotic translation initiation factor 2B, subunit 5 epsiloneukaryotic translation initiation factor 2B, subunit 5 εEIF2B ε
02

Mechanism of action

Inhibition (by phosphorylated eIF2α or by ISR-targeting compounds); Activation (by GTP recycling promotion on eIF2)

03

Biological functions

Protein synthesis regulationGuanine nucleotide exchange (GDP to GTP on eIF2)Integrated stress response regulationCellular stress adaptation
04

Disease associations

Neurodegenerative diseaseLeukoencephalopathy with vanishing white matter (VWM)Ovarioleukodystrophy
05

Safety considerations

Impaired response to cellular stress when targeted or mutatedPotential impact on global protein synthesis and cell viability
06

Interacting drugs

ISRIB
07

Biomarkers

EIF2B5 mutation status (for leukoencephalopathy with vanishing white matter)

Beyond the preview

Go deeper on Eukaryotic translation initiation factor 2B subunit epsilon (eIF2Bε).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic translation initiation factor 2B subunit epsilon (eIF2Bε).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call